Back to search

Article

SETD1A augments sorafenib primary resistance via activating YAP in hepatocellular carcinoma

2020-05-22

Abstract excerpt

<title>Abstract</title> <p><bold>Background</bold>: Sorafenib, the approved first-line chemotherapy drug for HCC, remains the key treatment agent which can effectively improve the survival rate of advanced HCC patients. However, the sorafenib primary resistance limits the application of sorafenib for HCC treatment. The aims of current study are to explore the role and mechanism of SETD1A (Histone Lysine Methyltra...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c5f3bf05-bd7a-5e7f-83a9-ee91681a2b14
DOI
10.21203/rs.3.rs-16967/v2
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
SETD1A augments sorafenib primary resistance via activating YAP in hepatocellular carcinomaDOI 10.21203/rs.3.rs-16967/v2
Comprehensive Network Analysis of the Molecular Mechanisms Associated with Sorafenib Resistance in Hepatocellular CarcinomaSemantic proximity
Bioinformatics analysis revealed hub genes and pathways involved in sorafenib resistance in hepatocellular carcinomaSemantic proximity
HTR1D regulates the PI3K/Akt signaling pathway to impact hepatocellular carcinoma development and resistance to sorafenibSemantic proximity
TAK1 Is a Novel Target in Hepatocellular Carcinoma and Contributes to Sorafenib Resistance.Semantic proximity
cDCBLD2 mediates sorafenib resistance in hepatocellular carcinoma by sponging miR-345-5p binding to the TOP2A coding sequenceSemantic proximity
Heterogeneity, Inherent and Acquired Drug Resistance in Patient-Derived Organoids Models of Primary Liver CancerSemantic proximity
Transcriptomic Profiling Identifies CSNK1E as a Key Mediator of Sorafenib Resistance in Hepatocellular CarcinomaSemantic proximity
MicroRNA-140-5p Suppresses The PD-L1 Level In Exosomes Derived From Hepatocellular Carcinoma Cells, Thereby Attenuating The Chemoresistance, Autophagy And Stemness Induced By Sorafenib In Hepatocellular CarcinomaSemantic proximity
Mitophagy Promotes Sorafenib Resistance through Hypoxia-Inducible ATAD3A Dependent AxisSemantic proximity
Artesunate Sensitizes human hepatocellular carcinoma to sorafenib via exacerbating AFAP1L2-SRC-FUNDC1 axis-dependent mitophagySemantic proximity
NOTCH1 regulates the DNA damage response and sorafenib resistance by activating ATM in hepatocellular carcinomaSemantic proximity
miR-183-5p attenuates the effect of sorafenib on human hepatocellular carcinoma via inhibiting SOCS6/JAK2/STAT3 pathwaySemantic proximity
Select a neighboring publication to make it the new centre.